Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abzena Receives $10M Investment from Biospring Partners | Contract Pharma

What are you searching for?

Sign in
Breaking News

Abzena Receives $10M Investment from Biospring Partners

New capital will allow Abzena to further accelerate its growth plans. Abzena drove 80% revenue growth and tripled GMP manufacturing capacity in 1H20.

By: Contract Pharma

Contract Pharma Staff

Abzena, a global partnership research organization providing discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a $10 million investment of growth capital from Biospring Partners, a New York based investment firm. 

The new capital will allow Abzena to further accelerate its growth plans. Abzena drove 80% revenue growth and tripled GMP manufacturing capacity in 1H20.

“The investment by Biospring Partners is further validation that the Abzena integrated model is the future of biologics drug development and manufacturing,” said Jonathan Goldman MD, CEO of Abzena. “Michelle Dipp and Jennifer Lum founded Biospring based upon their deep expertise in life sciences and technology industries. Abzena will benefit from Biospring’s access to a broad network of potential customers and their expertise in building and operating growth stage companies. Access to new customer partners and operating expertise is essential for the continuing growth of the company.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics